{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-004053","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.257828+00:00","generated_at":"2026-06-01T05:31:10.609557+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nasdaq notifies Sunshine Biopharma of delisting due to warrant dilution","bullets":["Nasdaq staff determined to delist SBFM under Rule 5101 citing public interest concerns over Series A warrant cashless exercise provision.","Provision allowed warrant holders to receive 2x shares without adjusting for 1-for-100 reverse split on April 17, 2024, causing massive shareholder dilution.","Company must present views to Nasdaq Hearings Panel by June 14, 2024; no immediate effect on listing pending panel decision."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-004053","json":"https://secwatch.observer/filing/0001683168-24-004053.json","markdown":"https://secwatch.observer/filing/0001683168-24-004053.md","text":"https://secwatch.observer/filing/0001683168-24-004053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316824004053/0001683168-24-004053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316824004053/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:31:10.609557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}